- Nano Express
- Open Access
Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
© Lio et al. 2016
- Received: 2 September 2015
- Accepted: 27 December 2015
- Published: 8 January 2016
Core-shell alginate-poly (lactic-co-glycolic) acid (PLGA) microparticles are potential candidates to improve hydrophilic drug loading while facilitating controlled release. This report studies the influence of the alginate core size on the drug release profile of alginate-PLGA microparticles and its size. Microparticles are synthesized through double-emulsion fabrication via a concurrent ionotropic gelation and solvent extraction. The size of alginate core ranges from approximately 10, 50, to 100 μm when the emulsification method at the first step is homogenization, vortexing, or magnetic stirring, respectively. The second step emulsification for all three conditions is performed with magnetic stirring. Interestingly, although the alginate core has different sizes, alginate-PLGA microparticle diameter does not change. However, drug release profiles are dramatically different for microparticles comprising different-sized alginate cores. Specifically, taking calcein as a model drug, microparticles containing the smallest alginate core (10 μm) show the slowest release over a period of 26 days with burst release less than 1 %.
- Alginate-PLGA microparticles
- Core-shell structure
- Drug delivery
Core-shell structures are synthesized through the combination of a polymeric core as well as another polymeric material over it [1–3]. Previous studies demonstrated that drug-loaded core-shell particles showed better controlled release compared to monolithic composite microparticles . As such, combinations of different polymers having dissimilar diffusion kinetics and degradation rates can be tuned to achieve better control over drug release .
Alginate-poly (lactic-co-glycolic) acid (alginate-PLGA) core-shell microparticles are promising drug carriers with high loading efficiency for hydrophilic drugs and good control over the drug release kinetics. They are composed of a hydrogel alginate core and a polyester PLGA shell. While hydrophilic drugs such as proteins can be encapsulated within the alginate core [6–9], the PLGA shell stabilizes the alginate core to prevent burst release and prolong drug release. Previously, Lim et al. reported the successful synthesis of alginate-PLGA microparticles via solvent extraction method and used them to deliver metoclopramide hydrochloride . Loading efficiency results showed a 29 % increase in encapsulation efficiency for alginate-PLGA compared to neat PLGA particles.
All materials except specifically mentioned were obtained from Sigma-Aldrich.
Synthesis of PLGA Microparticles
The PLGA microparticles were synthesized according to the published method . Briefly, 50 mg of PLGA (molecular weight (Mw) 30,000–60,000) was dissolved in 2 ml chloroform and mixed with 0.2 ml of calcein aqueous solution (1 mg/ml). This mixture was then homogenized at speed 25,600 rpm (Scilogex D160) for 10 s. Later, the solution was added dropwise to 20 ml of 3 % polyvinyl alcohol (PVA) (Mw 9000–10,000, 80 % hydrolyzed) aqueous solution under magnetic stirring at 600 rpm. These particles were termed homo-mag. The solution was placed in 40 °C water batch for 2.5 hrs. Finally, the PLGA microparticles were collected through centrifugation and washed with DI water trice. Vort-mag particles on the other hand were fabricated by vortexing at 2,500rpm for PLGA and magnetic stirring at 600rpm in PVA. Lastly for mag-mag particles both steps were done with magnetic stirring at 600 rpm.
Synthesis of Alginate-PLGA Microparticles
Fifty milligrams of PLGA was dissolved in 2 ml of chloroform with 1 % (w/v) Span 80. One milliliter of 1.35 M sodium chloride aqueous solution was mixed with 0.2 ml of calcein aqueous solution (1 mg/ml) and 0.2 ml of 4.5 % (w/v) sodium alginate aqueous solution. The aqueous mixture was then added into the PLGA solution and emulsified using homogenization, vortexing, or magnetic stirring. This water-oil emulsion was added dropwise into 20 ml of 3 % PVA solution containing 50 mM calcium chloride and 0.6 M sodium chloride under magnetic stirring. The solution was placed in 40 °C water batch for 2.5 h. Finally, the alginate-PLGA microparticles were collected through centrifugation and washed with DI water trice. Homo-mag, vort-mag, and mag-mag alginate-PLGA microparticles were fabricated as above.
SEM Characterization of Microparticles
The particles were lyophilized for 24 h . Then, the lyophilized particles were placed onto the carbon tape on the SEM stub. Excess loose particles could be removed using compressed air. The samples were then coated with platinum and imaged with JEOL JSM 6701F SEM under the beam strength of 5 kV .
Calculation of Calcein Encapsulation Efficiency
where M i is initial amount of calcein during the preparation and M s is the amount of non-encapsulated calcein in the supernatant .
Study of Calcein Release Profile from Microparticles
PLGA or alginate-PLGA microparticles (25 mg) were dispersed in 1 ml PBS at 37 °C. At 0 h, 2 h, days 1–6, 19, and 26, the particles were separated from the solution through centrifugation and dispersed in the fresh buffer. The supernatant was examined for their calcein concentration through fluorescence measurement (λ ex 485 nm; λ em 535 nm) . The release profile was derived based on the cumulative sum of released amounts at specific times.
Synthesis and Characterization of Alginate-PLGA Microparticles
To estimate the amount of encapsulated calcein by each particle formulation, the remaining calcein obtained from the supernatant (following double emulsion) was deducted from the input amount of calcein. Briefly, calcein concentration was determined by measuring the fluorescence of the supernatant and fitted to a standard curve generated from known concentrations (Additional file 1: Figure S1). The calculation showed that microparticles containing 10 or 50 μm alginate had encapsulation efficiency of over 90 % (Additional file 2: Figure S2). Microparticles containing 100 μm alginate core (monolithic-like particles) only had an efficiency of ~30 %.
Calcein Release Profile of Alginate-PLGA Microparticles
Further Examination of Alginate-PLGA Microparticles Containing 10 μm Alginate Core
Drug release systems promise improved delivery efficiency, enhanced patient compliance, and reduced side effects . Alginate-PLGA core-shell microparticle system is such a promising platform, in which the alginate core reserves the hydrophilic drugs while the PLGA shell entraps the core, tuning release profile. However, no studies have been performed to examine the influence of core size in core-shelled particles on drug release kinetics. This article aims to explore the influence of alginate core size on the overall size of alginate-PLGA microparticles and their release profile.
PLGA microparticles delivering hydrophilic payloads are often fabricated using a double emulsion solvent evaporation method, comprising: (a) preparing a water-in-oil (w/o) emulsion, (b) emulsifying the primary w/o within an aqueous phase containing surfactants, and (c) the organic solvent is evaporated to create the particles . In this study, the emulsifying method in step 1 was chosen from magnetic stirring, vortexing, or homogenization while other parameters were kept the same (Fig. 1). Varying the primary emulsion method worked as intended. Although the overall size of alginate-PLGA microparticles was similar, different-sized alginate cores were observed (Fig. 2). Specifically, reducing the rate of emulsification from homogenization (25,600 rpm) to vortexing (2500 rpm) to magnetic stirring (600 rpm), the alginate cores similarly increased from 10 to 50 to 100 μm. This was due to the different magnitudes of shear stress generated from various emulsification methods. Higher shear stress is a result of higher speed of emulsification [17, 18].
Alginate-PLGA microparticles showed higher encapsulation efficiency as compared to the corresponding particles without alginate core (Additional file 2: Figure S2 and Additional file 3: Figure S3). This improvement may be due to the high affinity between calcein and calcium ions which were used for gelation of alginate core [19, 20]. This allowed a greater quantity of calcein to be entrapped within particles bearing alginate cores.
Finally, the drug release profile of the influence of alginate core size was examined. Microparticles were dispersed in PBS at 37 °C for 26 days. As shown in Fig. 3a, smaller alginate core size resulted in slower calcein release. Previous study showed that drug release occurred when water diffuses into the interior causing drug dissolution and subsequently diffusion across the shell to the exterior [21, 22]. Thus, a high inner surface-area-to-volume ratio (homo-mag) provides a longer diffusion distance for water penetration into the core as compared to low inner surface-to-volume ratio (mag-mag), leading to a slower calcein release.
As compared to PLGA microparticles without alginate cores, alginate-PLGA microparticles surprisingly did not exhibit significant burst release (Fig. 3b). This observation may be a result of the high affinity between calcium ions and calcein, which hinders the release of calcein molecules [19, 20].
In this study, alginate-PLGA microparticles were synthesized through double emulsion solvent extraction and concurrent ionotropic gelation. The alginate core size was tuned by utilizing different emulsification techniques in the first emulsification step. A higher speed of emulsification produced a smaller alginate core. Taking calcein as a model drug, the alginate-PLGA particles with smaller alginate cores showed the slowest drug release. And compared with pure PLGA particles, burst release of drugs in all alginate-PLGA particles was significantly suppressed. In summary, the control of alginate core size in the alginate-PLGA core-shell microparticles proved to be an effective way to tailor the drug release profile.
The authors would like to thank Mr. Lim Jing for assisting the author with scanning electron microscope imaging. This research was supported by NTU-Northwestern Institute of Nanomedicine.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Chatterjee K, Sarkar S, Jagajjanani Rao K, Paria S (2014) Core/shell nanoparticles in biomedical applications. Adv Colloid Interf Sci 209:8–39. doi:10.1016/j.cis.2013.12.008 View ArticleGoogle Scholar
- Thatai S, Khurana P, Boken J, Prasad S, Kumar D (2014) Nanoparticles and core-shell nanocomposite based new generation water remediation materials and analytical techniques: a review. Microchem J 116:62–76. doi:10.1016/j.microc.2014.04.001 View ArticleGoogle Scholar
- Ghosh Chaudhuri R, Paria S (2012) Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications. Chem Rev 112(4):2373–433. doi:10.1021/cr100449n View ArticleGoogle Scholar
- Lim MPA, Lee WL, Widjaja E, Loo SCJ (2013) One-step fabrication of core-shell structured alginate-PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs. Biomater Sci 1(5):486–93. doi:10.1039/C3BM00175J View ArticleGoogle Scholar
- Park J, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10(1):146View ArticleGoogle Scholar
- Peng Z, Chen XB, David JS (2013) Preparation and characterization of alginate microspheres for sustained protein delivery within tissue scaffolds. Biofabrication 5(1):015009View ArticleGoogle Scholar
- Wells LA, Sheardown H (2007) Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique. Eur J Pharm Biopharm 65(3):329–35. doi:10.1016/j.ejpb.2006.10.018 View ArticleGoogle Scholar
- Silva CM, Ribeiro AJ, Ferreira D, Veiga F (2006) Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation. Eur J Pharm Sci 29(2):148–59. doi:10.1016/j.ejps.2006.06.008 View ArticleGoogle Scholar
- Martins S, Sarmento B, Souto EB, Ferreira DC (2007) Insulin-loaded alginate microspheres for oral delivery—effect of polysaccharide reinforcement on physicochemical properties and release profile. Carbohydr Polym 69(4):725–31. doi:10.1016/j.carbpol.2007.02.012 View ArticleGoogle Scholar
- Park JS, Yang HN, Woo DG, Jeon SY, Park K-H (2012) SOX9 gene plus heparinized TGF-β 3 coated dexamethasone loaded PLGA microspheres for inducement of chondrogenesis of hMSCs. Biomaterials 33(29):7151–63. doi:10.1016/j.biomaterials.2012.06.023 View ArticleGoogle Scholar
- Ito F, Honnami H, Kawakami H, Kanamura K, Makino K (2008) Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Colloids Surf B: Biointerfaces 67(1):20–5. doi:10.1016/j.colsurfb.2008.07.008 View ArticleGoogle Scholar
- McCarthy D. A closer look at PLGA microparticles, in infocus. March 2010. Issue 17, p. 20-23.Google Scholar
- Nafissi Varcheh N, Luginbuehl V, Aboofazeli R, Peter Merkle H (2011) Preparing poly (lactic-co-glycolic acid) (PLGA) microspheres containing lysozyme-zinc precipitate using a modified double emulsion method. Iran J Pharm Res 10(2):203–209Google Scholar
- Choi DH, Park CH, Kim IH, Chun HJ, Park K, Han DK (2010) Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. J Control Release 147(2):193–201. doi:10.1016/j.jconrel.2010.07.103 View ArticleGoogle Scholar
- Wu J, Kong T, Yeung KW, Shum HC, Cheung KM, Wang L et al (2013) Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomater 9(7):7410–9. doi:10.1016/j.actbio.2013.03.022 View ArticleGoogle Scholar
- Sushama T, MT, Zeenat I (2013) Formulations of nanoparticles in drug delivery. In: Arun Kumar HMM, Friedman A, Blough ER (eds) Nanomedicine in Drug Delivery. CRC Press: Boca Raton, Florida, USA. pp 239-286.Google Scholar
- Perrier-Cornet JM, Marie P, Gervais P (2005) Comparison of emulsification efficiency of protein-stabilized oil-in-water emulsions using jet, high pressure and colloid mill homogenization. J Food Eng 66(2):211–7. doi:10.1016/j.jfoodeng.2004.03.008 View ArticleGoogle Scholar
- Floury J, Legrand J, Desrumaux A (2004) Analysis of a new type of high pressure homogeniser. Part B. study of droplet break-up and recoalescence phenomena. Chem Eng Sci 59(6):1285–94. doi:10.1016/j.ces.2003.11.025 View ArticleGoogle Scholar
- Tambutté E, Tambutté S, Segonds N, Zoccola D, Venn A, Erez J et al (2012) Calcein labelling and electrophysiology: insights on coral tissue permeability and calcification. Proc Biol Sci 279(1726):19–27View ArticleGoogle Scholar
- Chiu VC, Haynes DH (1977) High and low affinity Ca2+ binding to the sarcoplasmic reticulum: use of a high-affinity fluorescent calcium indicator. Biophys J 18(1):3–22View ArticleGoogle Scholar
- Pavan Kumar B, Sarath Chandiran I, Bhavya B, Sindhuri M (2011) Microparticulate drug delivery system: a review. Indian J Pharm Sci Res 1(1):19–37Google Scholar
- Xu Q, Chin SE, Wang C-H, Pack DW (2013) Mechanism of drug release from double-walled PDLLA(PLGA) microspheres. Biomaterials 34(15):3902–11. doi:10.1016/j.biomaterials.2013.02.015 View ArticleGoogle Scholar